Skip to main content
Equibles
OSCR logo

OSCR · Oscar Health, Inc. · Metrics

Track OSCR — free

Use OSCR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OSCR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$30.13 -0.72 (-2.32%)
Russell 2000 member Rebalance outlook locked
Customer concentration — top customer 93% of revenue

One customer — 93% of revenue (the year ended December 31, 2025)

“For the year ended December 31, 2025, 93% of premiums were earned directly from CMS and 7% were from our members.”
View the 10-K filed Feb 13, 2026
Market Cap
$9.14B
Shares
308.64M
Volume · Oct 1 379.63K Avg daily vol (3M) 5.31M

OSCR metrics

73 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$30.84
Market cap
$9.14B

Price action

20 metrics
Price change (1W)
-2.9%
Price change (30D)
-0.6%
Price change (3M)
+4.4%
Price change (6M)
+159.5%
Price change (YTD)
+107.2%
Price change (1Y)
+55.6%
Trailing year
Price change (5Y)
+69.4%
52-week high
$33.81
52-week low
$10.85
Change from 52-week high
-11.9%
Change from 52-week low
+174.4%
Annualized volatility
70.2%
Annualized volatility (3M)
58.6%
Beta
1.5
RSI (14D)
43.2
Price vs SMA 50
-3.1%
Price vs SMA 200
+37.1%
Avg volume (3M)
5.33M
Relative volume
0.7
Average dollar volume
$162.83M

Company

3 metrics
Sector
Healthcare
Industry
Healthcare Plans
Shares outstanding
308.64M

Valuation

12 metrics
P / E (TTM)
20.5
Trailing earnings · reciprocal yield 4.9%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.6×
reciprocal yield 167.7%
P / book
4.5
reciprocal yield 22.5%
FCF yield
47.9%
TTM · current market cap
Buyback yield
—
P / FCF
2.1
reciprocal yield 47.9%
P / operating cash flow
2.1
reciprocal yield 48.4%
Earnings yield
6.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
4.1%
Trailing 12 months
Net margin
3.6%
Gross profit (TTM)
—
Operating profit (TTM)
$629.72M
Net income (TTM)
$550.74M
Trailing 12 months
Diluted EPS (TTM)
$1.45
FCF margin
28.6%
Effective tax rate
6.6%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+70.4%
Year over year
Net income growth YoY
-1,842.5%
Revenue (TTM)
$15.32B
Trailing 12 months
EPS growth YoY
-1,790.0%
Shares change YoY
+30.5%
Year over year · more shares
Revenue CAGR (3Y)
+43.5%
Revenue CAGR (5Y)
+90.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+44.4%
FCF CAGR (5Y)
+38.4%

Quality

14 metrics
Return on equity
26.8%
Return on assets
4.9%
Debt / equity
0.2
Current ratio
1.1
EBITDA (TTM)
$657.96M
Free cash flow (TTM)
$4.38B
Quick ratio
1.1
Interest coverage
39.7
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$4.08B
Total assets
$11.23B
Total debt
$431.63M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$4.42B
Capital expenditures (TTM)
$38.62M
R&D (TTM)
—
SG&A (TTM)
$2.43B
Stock compensation (TTM)
$75.19M
R&D / revenue
—
Stock compensation / revenue
0.5%

Ownership (13F)

3 metrics
13F filers
409
13F filer change QoQ
+72
Institutional ownership
72.1%

Short interest

3 metrics
Short interest
5.8%
Latest settlement · 3.7 days to cover
Days to cover
3.7d
Short-squeeze score
61 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$26.76M
Insider-sentiment score
15 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1568651 CUSIP 687793109 13F (30d) 11 filings 9 filers Visit website Investor relations